| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy. | Mol Ther | 2011 | 1.39 |
| 2 | Tetrahydro-1,8-naphthyridinol analogues of alpha-tocopherol as antioxidants in lipid membranes and low-density lipoproteins. | J Am Chem Soc | 2007 | 0.83 |
| 3 | Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity. | Mol Ther | 2010 | 0.81 |